{"title":"Correction to ‘Insulin-Like Growth Factor 2 (IGF-2) Potentiates BMP-9-Induced Osteogenic Differentiation and Bone Formation’","authors":"","doi":"10.1002/jbmr.4830","DOIUrl":null,"url":null,"abstract":"<p>\n <span>Chen, L</span> <span>Jiang, W</span>, <span>Huang, J</span>, <span>He, B-C</span>, <span>Zuo, G-W</span>, <span>Zhang, W</span>, <span>Luo, Q</span>, <span>Shi, Q</span>, <span>Zhang, B-Q</span>, <span>Wagner, ER</span>, <span>Luo, J</span>, <span>Tang, M</span>, <span>Wietholt, C</span>, <span>Luo, X</span>, <span>Bi, Y</span>, <span>Su, Y</span>, <span>Liu, B</span>, <span>Kim, SH</span>, <span>He, CJ</span>, <span>Hu, Y</span>, <span>Shen, J</span>, <span>Rastegar, F</span>, <span>Huang, E</span>, <span>Gao, Y</span>, <span>Gao, J-L</span>, <span>Zhou, J-Z</span>, <span>Reid, RR</span>, <span>Luu, HH</span>, <span>Haydon, RC</span>, <span>He, T-C</span>, <span>Deng, Z-L</span> (<span>2010</span>) <span>Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation</span>. <i>J Bone Miner Res.</i> 2010; <span>25</span>(<span>11</span>): <span>2447</span>–<span>2459</span>. doi: https://doi.org/10.1002/jbmr.133\n </p><p>In the published article, the authors found an image assembly error in <b>Figure 1C</b>, in which the image for “C3H10T1/2 (Ad-IGFP)” group was erroneously duplicated with the image from the “BMP9 + RFP” group of <b>Figure 3A</b>. The corrected figure is shown below. As shown in the corrected <b>Figure 1C</b>, this error does not adversely impact the conclusion of the original work. The authors apologize for any inconvenience caused by the error to the journal and scientific community.</p>","PeriodicalId":185,"journal":{"name":"Journal of Bone and Mineral Research","volume":"38 6","pages":"929"},"PeriodicalIF":5.1000,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jbmr.4830","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone and Mineral Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbmr.4830","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Chen, LJiang, W, Huang, J, He, B-C, Zuo, G-W, Zhang, W, Luo, Q, Shi, Q, Zhang, B-Q, Wagner, ER, Luo, J, Tang, M, Wietholt, C, Luo, X, Bi, Y, Su, Y, Liu, B, Kim, SH, He, CJ, Hu, Y, Shen, J, Rastegar, F, Huang, E, Gao, Y, Gao, J-L, Zhou, J-Z, Reid, RR, Luu, HH, Haydon, RC, He, T-C, Deng, Z-L (2010) Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010; 25(11): 2447–2459. doi: https://doi.org/10.1002/jbmr.133
In the published article, the authors found an image assembly error in Figure 1C, in which the image for “C3H10T1/2 (Ad-IGFP)” group was erroneously duplicated with the image from the “BMP9 + RFP” group of Figure 3A. The corrected figure is shown below. As shown in the corrected Figure 1C, this error does not adversely impact the conclusion of the original work. The authors apologize for any inconvenience caused by the error to the journal and scientific community.
期刊介绍:
The Journal of Bone and Mineral Research (JBMR) publishes highly impactful original manuscripts, reviews, and special articles on basic, translational and clinical investigations relevant to the musculoskeletal system and mineral metabolism. Specifically, the journal is interested in original research on the biology and physiology of skeletal tissues, interdisciplinary research spanning the musculoskeletal and other systems, including but not limited to immunology, hematology, energy metabolism, cancer biology, and neurology, and systems biology topics using large scale “-omics” approaches. The journal welcomes clinical research on the pathophysiology, treatment and prevention of osteoporosis and fractures, as well as sarcopenia, disorders of bone and mineral metabolism, and rare or genetically determined bone diseases.